Source:http://linkedlifedata.com/resource/pubmed/id/11751754
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-12-25
|
pubmed:abstractText |
T cell-dependent Ig production involves interaction between T cells and B cells. This study evaluated the effects of prostaglandin (PG) E(2) on Ig production in a system in which B cells were co-cultured with autologous CD4(+) T cell clones non-specifically activated by anti-CD3. The effects of PGE(2) on T cell-dependent Ig production differed substantially, depending on the T cells employed. We selected six T cell clones that were able to enhance Ig production (resistant T cell clones) and six T cell clones that inhibited Ig production in the presence of PGE(2) (sensitive T cell clones) for comparison. The resistant T cells produced high levels (>1000 pg/ml) of IL-2 and/or IL-4, and expressed high CD40L, OX40 and CD45RA, and low CD45RO. In contrast, sensitive T cells secreted low IL-2 (<500 pg/ml) and IL-4 (<200 pg/ml), and expressed low CD40, OX40 and CD45RA, and high CD45RO. Adding supernatant derived from resistant T cell clones restored Ig production inhibited by PGE(2), while removing IL-2, IL-4 or IL-10 using specific antibodies inhibited Ig production. In addition, we demonstrated a direct effect of PGE(2) on B cells to enhance Ig production. Consistently, in the presence of resistant T cells, PGE(2) increased B cell proliferation and differentiation. In conclusion, the effects of PGE(2) on Ig production consist of its indirect effects through T cells and its direct effects on B cells. The outcome of the effects can be up-regulatory or down-regulatory, depending whether resistant or sensitive T cells are involved.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD27,
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD3,
http://linkedlifedata.com/resource/pubmed/chemical/CD40 Ligand,
http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/Interleukins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, OX40,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Tumor Necrosis Factor,
http://linkedlifedata.com/resource/pubmed/chemical/TNFRSF4 protein, human
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0953-8178
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
69-77
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11751754-Antigens, CD27,
pubmed-meshheading:11751754-Antigens, CD3,
pubmed-meshheading:11751754-B-Lymphocytes,
pubmed-meshheading:11751754-CD4-Positive T-Lymphocytes,
pubmed-meshheading:11751754-CD40 Ligand,
pubmed-meshheading:11751754-Cells, Cultured,
pubmed-meshheading:11751754-Dinoprostone,
pubmed-meshheading:11751754-Down-Regulation,
pubmed-meshheading:11751754-Humans,
pubmed-meshheading:11751754-Immunoglobulins,
pubmed-meshheading:11751754-Interleukins,
pubmed-meshheading:11751754-Lymphocyte Activation,
pubmed-meshheading:11751754-Receptors, OX40,
pubmed-meshheading:11751754-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:11751754-T-Lymphocytes,
pubmed-meshheading:11751754-Th1 Cells,
pubmed-meshheading:11751754-Th2 Cells
|
pubmed:year |
2002
|
pubmed:articleTitle |
Bi-directional modulation of T cell-dependent antibody production by prostaglandin E(2).
|
pubmed:affiliation |
Research Service 151, VA Medical Center Memphis, 1030 Jefferson Avenue, TN 38104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.
|